$DOCU

GRAYSON BLAKE JEFFREY sold $683K of DOCU

GRAYSON BLAKE JEFFREY (Chief Financial Officer) sold 15,000 shares of DOCUSIGN, INC. (DOCU) at an average of $45.55 ($45.53–$45.99, $0.68M total) across 2 trades on 2026-07-01 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · GRAYSON BLAKE JEFFREY
Published Jul 2, 2026, 12:19 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 2, 2026, 12:31 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$DOCU
Neutral
medium confidence
Mentioned
$DOCU
Relevance
4/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$DOCUNeutralLow
01

Why it matters

The newest fact is the disclosed sale size, price range, and that it was executed under a pre-arranged 10b5-1 plan; no new business or financial guidance is included.

02

Market read

Traders may note the insider sale for sentiment, but the 10b5-1 structure reduces the informational edge versus an unplanned sale.

03

What to watch

The article provides only the sale details; it does not indicate whether other insiders bought/sold, nor any concurrent company news that could change the read-through.

Relevance 4/10Novelty 3/10Timing: Filed on 2026-07-01 after-hours; reflects sale executed that day.

Background

This is an SEC Form 4 insider transaction disclosure for DocuSign, Inc. (DOCU) by its CFO.

Company-level read

Ticker impact

$DOCUNeutralMedium confidence
Context

DocuSign CFO Grayson Blake Jeffrey filed an SEC Form 4 selling 15,000 shares at ~$45.53–$45.99 under a 10b5-1 plan.

Expected impact

Low likelihood of a sustained price move solely from this Form 4; any impact would be short-lived.

Evidence & confidence

The filing is a pre-arranged 10b5-1 open-market sale by the CFO, with no accompanying operational or guidance change disclosed in the text.

Market effects

Minimal; insider-sale disclosures rarely reset sector expectations without additional company-specific catalysts.

None indicated.

None indicated.

Counterpoint

Because it’s a 10b5-1 plan, the sale may be more about liquidity/tax planning than bearish fundamentals, so traders may ignore it.

Key entities

  • DOCUSIGN, INC.

    Subject of the Form 4 insider transaction; CFO sold shares under a 10b5-1 plan.

  • GRAYSON BLAKE JEFFREY

    DocuSign CFO who sold 15,000 shares on 2026-07-01.

Related articles

$LULUMed

Stock Market Today: Dow Futures Gain, S&P 500 Slips As Trump Floats Meeting Iran's Supreme Leader— Lulule

U.S. stock futures were mixed Friday: Nasdaq 100 and S&P 500 slipped while Dow futures rose after a mixed prior close. President Trump said he would consider meeting Iran’s Supreme Leader Ayatollah Mojtaba Khamenei if diplomacy progresses. Treasury yields were 4.46% (10-year) and 4.03% (2-year); FedWatch priced a 96.4% chance of no June rate change. Lululemon, Docusign (-4.73%), Samsara (-5.14%), and Keel (-8.94% on $350m convertibles) were among movers.

$LULUHighAI 9/10

Stocks making the biggest moves after hours: Lululemon Athletica, ServiceTitan, Argan and more

After-hours movers: Lululemon shares fell 10% after it cut full-year earnings and revenue guidance and its current-quarter outlook missed analyst expectations, per LSEG. Docusign slipped 4% as its Q2 revenue outlook ($865M–$869M) met but didn’t beat estimates. Guidewire dropped 16% on weaker adjusted gross margin. ServiceTitan rose 12% after raising full-year guidance.

$DOCUMedAI 9/10

DocuSign Delivers Beat-And-Raise Q1, But Investors Aren't Impressed - Docusign (NASDAQ:DOCU)

DocuSign reported Q1 revenue of $830.2 million, slightly above the $824.77 million consensus, and adjusted EPS of $1.09 versus $0.99 expected, according to Benzinga Pro. Revenue rose 9% YoY; free cash flow was $289.4 million. The company repurchased $317.5 million of stock and raised FY revenue guidance to $3.49–$3.502 billion. Shares were down 4.02% after hours to $48.85.

$DOCUMedAI 9/10

DocuSign (DOCU) Q1 Earnings Report Preview: What To Look For

DocuSign will report Q1 results Thursday after the bell, according to the article. The company’s prior quarter revenue was $836.9 million (+7.8% YoY), but it missed annual recurring revenue estimates. For Q1, analysts expect revenue +8.1% YoY. The article cites an average analyst price target of $59.88 vs. $55.18.